Theravance Biopharma Inc Financial Ratios — TBPH Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-68.39	-64.27	-122.65	- -	- -	- -	- -	- -	-16.86	-29.04	44.85
Return on Assets (%)	- -	-1,241.48	-130.62	-57.13	-40.6	-52.82	-43.03	-48.8	-63.34	-47.26	177.58	-11.16	-15.33	25.22
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	38.21
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.02
Gross Margin (%)	100	100	65.28	88.95	94.05	60.81	98.82	100	100	100	100	100	100	100
EBITDA Margin (%)	-4.86	-67,978.32	-1,961.54	-424.7	-364.55	-1,664.47	-390.24	-334.68	-404.49	-414.1	-140.41	-85.39	-60.3	-0.74
Operating Margin (%)	-7.36	-69,152.21	-1,989.55	-431.8	-370.96	-1,690.65	-395.48	-343.14	-414.19	-429.65	-154.09	-92.8	-65.91	-3.35
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-7.36	-69,152.21	-1,973.6	-430.3	-371.15	-1,765.96	-374.5	-329.2	-422.15	-479.51	-180.76	-85.8	-69.3	120.27
Profit Margin (%)	-7.36	-69,152.21	-2,028.05	-432.56	-391.94	-1,854.97	-357.01	-322.08	-386.9	-360.55	1,698.54	-96.11	-87.63	98.54
Net Income to Common Margin (%)	-7.36	-69,152.21	-2,028.05	-432.56	-391.94	-1,854.97	-357.01	-322.08	-386.9	-360.55	1,698.54	-96.11	-87.63	98.54
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.07
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-68.39	-64.27	-122.65	- -	- -	- -	- -	- -	-16.86	-29.04	44.85

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	223	224	454	511	676	670	52	49	50	43
ST Debt	- -	- -	- -	- -	- -	- -	- -	18	29	17	7	4	11	11
LT Debt	- -	- -	- -	- -	223	224	454	493	647	652	45	45	39	32
Total Debt/EBITDA	- -	- -	- -	- -	-1.26	-0.87	-1.93	-2.08	-2.33	-2.92	-0.72	-1	-1.28	-53.99
Net Debt/EBITDA	- -	- -	0.39	0.63	0.69	-0.53	-0.32	-1.62	-1.85	-2.3	4.14	0.81	0.97	212.14
Total Debt/EBIT	- -	- -	- -	- -	-1.23	-0.86	-1.9	-2.03	-2.27	-2.82	-0.66	-0.92	-1.17	-11.86
Net Debt/EBIT	- -	- -	0.38	0.62	0.68	-0.52	-0.32	-1.58	-1.81	-2.21	3.77	0.74	0.89	46.59
EBITDA to Interest Expense	- -	- -	- -	- -	-126.32	-29.96	-22.48	-7.71	-34.01	-26.8	-11.32	-20.87	-15.25	-0.32
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-127.84	-30.24	-23.17	-7.81	-34.78	-27.2	-11.41	-21.93	-15.38	-0.34
EBIT to Interest Expense	- -	- -	- -	- -	-128.54	-30.43	-22.78	-7.91	-34.82	-27.8	-12.42	-22.68	-16.67	-1.46
Interest Expense	- -	- -	- -	- -	1	9	10	32	9	9	6	2	3	2
Common Equity/Total Assets	- -	-67.66	85.79	80.99	54.79	26.09	-9.21	-54.75	-64.76	-90.33	72.74	55.76	49.57	61.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	- -	- -	- -	- -	10.28	21.24	22.28	10.7
Long-Term Debt/Capital (%)	- -	- -	- -	- -	38.87	66.02	112.81	171.93	173.7	197.03	9.19	17.26	17.35	9.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	120.57	137.95	173.97	7.48	11.84	11.04	6.54
Total Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	-880.72	-228.08	-222.64	-197.75	11.81	23.08	28.38	14.39
Total Debt/Capital (%)	- -	- -	- -	- -	38.87	66.02	112.81	178.08	181.54	202.3	10.56	18.75	22.11	12.58
Total Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	124.88	144.17	178.62	8.59	12.87	14.07	8.79
Net Debt to Equity	- -	- -	-30.79	-46.37	-34.84	117.01	-147.96	-177.35	-177.02	-155.47	-67.49	-18.57	-21.53	-56.55
Net Debt/Capital (%)	- -	- -	-44.48	-86.46	-53.48	53.92	308.5	173.64	184.75	218.43	-152.29	-17.76	-20.15	-97.78
EBITDA	-6	-154	-229	-179	-177	-256	-236	-246	-291	-229	-72	-49	-39	-1
EBITDA-CapEx	-9	-156	-232	-182	-179	-259	-243	-249	-297	-232	-73	-52	-39	-1
Operating Income (Loss)	-10	-156	-233	-182	-180	-260	-239	-252	-298	-238	-79	-53	-42	-4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	- -	6.17	3.49	10.17	5.57	5.13	2.51	2.37	2.96	11.4	4.14	2.75	8.23
Current Ratio	- -	0.38	6.67	4.8	10.73	6.05	5.41	3.03	3.18	4.26	12.31	5.39	5.02	10.93
Quick Ratio	- -	0.03	6.22	4.24	10.37	5.72	5.29	2.97	2.93	3.94	11.99	4.84	4.89	10.73
CFO/Avg Current Liab	- -	-6.56	-4.48	-3.72	-2.01	-3.6	-1.4	-2.27	-2.13	-2.28	-4.28	-1.01	-0.41	6.78
Common Equity/Total Assets	- -	-67.66	85.79	80.99	54.79	26.09	-9.21	-54.75	-64.76	-90.33	72.74	55.76	49.57	61.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	- -	- -	- -	- -	10.28	21.24	22.28	10.7
Long-Term Debt/Capital (%)	- -	- -	- -	- -	38.87	66.02	112.81	171.93	173.7	197.03	9.19	17.26	17.35	9.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	120.57	137.95	173.97	7.48	11.84	11.04	6.54
Total Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	-880.72	-228.08	-222.64	-197.75	11.81	23.08	28.38	14.39
Total Debt/Capital (%)	- -	- -	- -	- -	38.87	66.02	112.81	178.08	181.54	202.3	10.56	18.75	22.11	12.58
Total Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	124.88	144.17	178.62	8.59	12.87	14.07	8.79
CFO/Total Liabilities	- -	-286.55	-365.03	-295.98	-34.25	-61.63	-18.45	-37.65	-32.4	-29.14	-112.92	-15.97	-6.46	126.31
CFO/CapEx	-45.99	-44.24	-56.37	-63.79	-46.36	-83.56	-15.59	-75	-37.85	-61.03	-326.91	-10.85	-34.74	5,679.55
Altman's Z-Score	- -	-22.51	4.03	3.94	2.42	-0.79	-1.5	-4.06	-4.92	-7.09	0.98	-1.38	-2.03	1.69

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	0.4	7.17	2.14	2.08	1.61	6.03	4.49	3.8	3.7	3.33	3.35	3.59	3.36
Days Sales Outstanding	- -	914.92	50.93	170.18	175.85	226.36	60.57	81.21	96.17	98.76	109.65	108.88	101.8	108.65
Inventory Turnover	- -	- -	0.35	0.41	0.26	0.42	0.08	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	1,032.22	883.74	1,401.54	879.21	4,295.77	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	3	0.74	0.15	0.5	2.78	-2.16	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	121.71	496.47	2,477.46	733.61	131.33	-169.33	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	586.68	-1,423.54	843.79	974.24	4,525.66	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	-981.28	-713.55	-1,225.69	-652.84	-4,235.2	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	10	13	10	12	17	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	5	7	7	6	12	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	5	6	3	4	5	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	481	623	1,684	1,517	1,425	1,476	1,143	823	732	541	466	955
- Cash & Cash Equivalents	- -	- -	89	113	345	89	378	58	81	90	298	40	38	168
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	223	224	454	511	676	670	52	49	50	43
Enterprise Value	- -	- -	226	450	1,406	1,392	1,374	1,706	1,526	1,319	457	487	427	683
Total Capital	- -	-17	290	243	573	339	403	287	373	331	494	262	225	339
Total Debt/Capital (%)	- -	- -	- -	- -	38.87	66.02	112.81	178.08	181.54	202.3	10.56	18.75	22.11	12.58
Total Debt / EV	- -	- -	- -	- -	0.16	0.16	0.33	0.3	0.44	0.51	0.11	0.1	0.12	0.06
EV/Sales	- -	- -	19.35	10.68	28.9	90.46	22.76	23.24	21.24	23.84	8.89	8.49	6.63	6.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.84
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.84
Diluted Market Cap	- -	- -	474	560	1,425	1,460	1,381	1,440	1,108	768	826	622	460	964
Diluted Enterprise Value	- -	- -	385	447	1,303	1,595	1,457	1,892	1,703	1,347	580	631	472	839
EV per Share	- -	- -	7.02	11.85	26.61	25.59	24.68	29.92	23.73	17.71	7	10.13	8.63	13.37
TTM Sales	130	- -	12	42	49	15	60	73	72	55	51	57	64	107
TTM EBITDA	-6	-154	-229	-179	-177	-256	-236	-246	-291	-229	-72	-49	-39	-1
TTM Operating Income	-10	-156	-233	-182	-180	-260	-239	-252	-298	-238	-79	-53	-42	-4
TTM Cash Flow to Firm	-119	-121	-175	-169	-98	-192	-103	-207	-242	-199	-181	-24	-8	241
TTM Free Cash Flow to Firm	-117	-118	-172	-166	-95	-190	-96	-204	-235	-196	-180	-22	-8	241

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-2.75	-3.37	-14.72	-7.35	-13.07	-6.13	-4.54	-3.75	-4.43	-25.36	-41.03	4.04
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	226	450	1,406	1,392	1,374	1,706	1,526	1,319	457	487	427	683
Low Price	- -	- -	13.11	10.56	12.87	23.15	21.27	15.18	14.48	6.1	7.53	8.25	7.44	7.9
EV/Sales	- -	- -	19.35	10.68	28.9	90.46	22.76	23.24	21.24	23.84	8.89	8.49	6.63	6.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.95	- -	- -	8.89
Price/Earnings Average	- -	- -	-3.21	-2.92	-5.69	-6.09	-6.6	-5	-4.89	-5	0.82	-10.35	-7.8	5.76
Price/Earnings High	- -	- -	-4.78	-4.12	-9.13	-7.97	-8.88	-6.73	-7.07	-7.92	1.11	-12.05	-10.14	9.66
Price/Earnings Low	- -	- -	-1.76	-1.98	-3.02	-4.25	-5.33	-3.57	-3.25	-2.12	0.64	-8.27	-6.44	3.75
Price/Book Value	- -	- -	1.66	2.56	4.81	13.17	-27.62	-6.59	-3.76	-2.43	1.66	2.54	2.65	3.22
Price/Book Value Average	- -	- -	2.66	2.43	3.66	15.66	-28.44	-5.42	-4.62	-3.15	1.44	2.33	2.54	2.09
Price/Book Value High	- -	- -	3.97	3.44	5.87	20.51	-38.29	-7.29	-6.68	-5	1.94	2.72	3.3	3.5
Price/Book Value Low	- -	- -	1.46	1.65	1.94	10.93	-22.96	-3.87	-3.07	-1.34	1.11	1.86	2.1	1.36
Price/Tangible Book Value	- -	- -	1.66	2.56	4.81	13.17	-27.62	-6.59	-3.76	-2.43	1.66	2.54	2.65	3.22
Price/Tangible Book Value Average	- -	- -	2.66	2.43	3.66	15.66	-28.44	-5.42	-4.62	-3.15	1.44	2.33	2.54	2.09
Price/Tangible Book Value High	- -	- -	3.97	3.44	5.87	20.51	-38.29	-7.29	-6.68	-5	1.94	2.72	3.3	3.5
Price/Tangible Book Value Low	- -	- -	1.46	1.65	1.94	10.93	-22.96	-3.87	-3.07	-1.34	1.11	1.86	2.1	1.36
Price/Sales	- -	- -	40.54	13.29	29.3	94.9	22.88	19.61	15.42	13.88	16.08	10.82	7.14	8.76
Price/Sales Average	- -	- -	65.11	12.63	22.31	112.89	23.55	16.11	18.92	18.02	13.94	9.95	6.84	5.68
Price/Sales High	- -	- -	96.93	17.83	35.77	147.81	31.72	21.69	27.36	28.56	18.88	11.59	8.88	9.52
Price/Sales Low	- -	- -	35.62	8.56	11.83	78.78	19.01	11.5	12.56	7.66	10.79	7.95	5.64	3.7
Price/Cash Flow	- -	- -	-2.7	-3.31	-14.4	-7.26	-12.24	-6.04	-4.42	-3.69	-4.42	-23.02	-39.85	3.95
Price/Cash Flow Average	- -	- -	-4.34	-3.15	-10.96	-8.64	-12.6	-4.97	-5.43	-4.8	-3.83	-21.16	-38.15	2.56
Price/Cash Flow High	- -	- -	-6.47	-4.45	-17.58	-11.31	-16.97	-6.68	-7.85	-7.6	-5.18	-24.64	-49.59	4.29
Price/Cash Flow Low	- -	- -	-2.38	-2.14	-5.81	-6.03	-10.17	-3.54	-3.61	-2.04	-2.96	-16.9	-31.51	1.67
Price/Free Cash Flow Average	- -	- -	-4.42	-3.2	-11.2	-8.74	-13.46	-5.03	-5.58	-4.88	-3.84	-23.31	-39.29	2.62
Price/Free Cash Flow High	- -	- -	-6.58	-4.52	-17.97	-11.45	-18.13	-6.77	-8.07	-7.73	-5.2	-27.14	-51.06	4.39
Price/Free Cash Flow Low	- -	- -	-2.42	-2.17	-5.94	-6.1	-10.87	-3.59	-3.7	-2.07	-2.97	-18.62	-32.44	1.71
EV/Sales Average	- -	- -	58.43	11.37	23.85	126.02	25.56	22.68	27.8	29.79	7.56	8.82	7.11	4.6
EV/Sales High	- -	- -	90.71	17.16	39.76	162.3	33.99	28.4	36.51	41.08	11.94	10.24	9.18	8.5
EV/Sales Low	- -	- -	28.51	6.85	11.47	90.59	20.88	17.95	21.24	18.69	4.77	7.08	5.9	2.59
EV/EBITDA Average	- -	- -	-2.98	-2.68	-6.54	-7.57	-6.55	-6.78	-6.87	-7.19	-5.38	-10.33	-11.79	-624.71
EV/EBITDA High	- -	- -	-4.62	-4.04	-10.91	-9.75	-8.71	-8.49	-9.03	-9.92	-8.5	-11.99	-15.23	-1,154.39
EV/EBITDA Low	- -	- -	-1.45	-1.61	-3.15	-5.44	-5.35	-5.36	-5.25	-4.51	-3.4	-8.29	-9.79	-351.88
EV/EBIT Average	- -	- -	-2.94	-2.63	-6.43	-7.45	-6.46	-6.61	-6.71	-6.93	-4.91	-9.5	-10.79	-137.19
EV/EBIT High	- -	- -	-4.56	-3.97	-10.72	-9.6	-8.59	-8.28	-8.82	-9.56	-7.75	-11.04	-13.93	-253.5
EV/EBIT Low	- -	- -	-1.43	-1.59	-3.09	-5.36	-5.28	-5.23	-5.13	-4.35	-3.1	-7.63	-8.96	-77.27
Last Price	- -	- -	14.92	16.39	31.88	27.89	25.59	25.89	17.77	11.05	11.22	11.24	9.41	18.71
High Price	- -	- -	35.67	22	38.92	43.44	35.48	28.63	31.54	22.74	13.17	12.03	11.71	20.33
Enterprise Value Average	- -	- -	683	479	1,160	1,939	1,543	1,665	1,998	1,648	388	506	458	494
Enterprise Value High	- -	- -	1,060	723	1,934	2,497	2,052	2,085	2,624	2,272	613	588	591	913
Enterprise Value Low	- -	- -	333	288	558	1,394	1,261	1,318	1,526	1,034	245	406	380	278

Shares Outstanding	- -	32	32	38	53	54	56	57	64	74	65	48	49	51
Diluted Weighted Avg Shares	32	32	32	34	45	52	54	56	62	69	74	55	49	52
Basic Weighted Avg Shares	32	32	32	34	45	52	54	56	62	69	74	55	49	50
Revenue per Share	4.03	0.01	0.37	1.23	1.09	0.29	1.12	1.32	1.15	0.8	0.7	1.04	1.32	2.14
EBITDA per Share	-0.2	-4.76	-7.22	-5.24	-3.97	-4.89	-4.37	-4.42	-4.66	-3.3	-0.98	-0.89	-0.79	-0.02
Operating Income per Share	-0.3	-4.84	-7.32	-5.33	-4.04	-4.97	-4.42	-4.53	-4.77	-3.42	-1.08	-0.96	-0.87	-0.07
Basic EPS, GAAP	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.46	-2.87	11.85	-1	-1.15	2.1
Basic EPS from Cont Ops	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.73	-3.82	-1.26	-1	-1.15	2.1
Diluted EPS, GAAP	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.46	-2.87	11.85	-1	-1.15	2.06
Diluted EPS from Cont Ops	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.73	-3.82	-1.26	-1	-1.15	2.06
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.69	-3.75	-5.52	-4.94	-2.21	-3.84	-2.09	-4.28	-4.02	-2.99	-2.54	-0.49	-0.24	4.74
Free Cash Flow per Basic Share	-3.77	-3.83	-5.61	-5.02	-2.26	-3.89	-2.23	-4.34	-4.12	-3.04	-2.55	-0.53	-0.24	4.74
Cash & Equivalents per Share	- -	- -	7.9	4.54	9.48	6.41	9.07	4.93	4.55	2.33	5.02	2.13	1.79	6.18
Book Value per Share	- -	-0.53	8.99	6.4	6.63	2.12	-0.93	-3.93	-4.72	-4.55	6.77	4.43	3.55	5.81
Tangible Book Value per Share	- -	-0.53	8.99	6.4	6.63	2.12	-0.93	-3.93	-4.72	-4.55	6.77	4.43	3.55	5.81

Theravance Biopharma Inc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)